ArticleBioprocess and biosystems engineering2025
Hybrid dynamic flux balance modeling approach for bioprocesses: an E. coli case study.
Article in Bioprocess and biosystems engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- dAMN: a genome-scale neural-mechanistic hybrid model to predict bacterial growth dynamics.Bioinformatics (Oxford, England) · 2026Article
- Quantifying and comparing causal patterns in stochastic chemical reaction networks.NPJ systems biology and applications · 2026Article
- Advancing hybrid modeling of Saccharomyces cerevisiae fermentation with mixed carbon sources and urea in a mini-stirred tank reactor.Bioprocess and biosystems engineering · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In this study, we present a hybrid dynamic flux balance analysis (DFBA) model, combined with Partial Least Squares (PLS) regression, to simulate cell culture behavior in response to variations in media composition. DFBA models typically incorporate a stoichiometric matrix representing metabolic reactions, leveraging the pseudo-stationarity assumption to reduce the number of parameters, which in turn minimizes the risk of overfitting. Here, PLS regression is employed to define kinetic rate constraints within the DFBA model, capturing the dynamic and non-linear nature of reaction rates over different culture phases. An optimization approach identifies the minimal number of kinetic constraints required, ensuring model accuracy without excessive complexity. Our hybrid model is validated through simulation case studies using an E. coli system, demonstrating its effectiveness in adjusting to changes in initial media composition. The case studies reveal that the model's accuracy improves with a more detailed stoichiometric matrix, particularly when larger networks or more varied metabolic environments are present. Additionally, the hybrid DFBA-PLS approach provides a robust and scalable modeling framework adaptable to other bioprocesses, offering insights into medium composition effects and highlighting its potential for bioprocess optimization.
Indexed as
Identifiers
40133554What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.